top of page
  • Writer's pictureWashington Business Journal

Md. biotech seeks backing for rare shift in its legal status

One of the D.C. region’s largest biotechs is working to be among the first publicly traded companies in its industry to convert to a public benefit corporation — an entity that must answer to both shareholders and society at large.

United Therapeutics Corp. (NASDAQ: UTHR) will seek approval from those shareholders at a Sept. 30 meeting to make the change in its certificate of incorporation, after which it would not only report financial results but also its effect on environmental, social and governance priorities on a regular basis. Company officials say the legal change will not alter its business or leadership strategy.


Read the full story in the Washington Business Journal.


Comments


bottom of page